Charlotte Nielsen-Kilstrup
Busto Arsizio, 21052, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Loss of CDKL5 Causes Synaptic GABAergic Defects That Can Be Restored with the Neuroactive Steroid Pregnenolone-Methyl-Ether.
Journal: International journal of molecular sciences
Published: November 02, 2022
Pregnenolone-methyl-ether enhances CLIP170 and microtubule functions improving spine maturation and hippocampal deficits related to CDKL5 deficiency.
Journal: Human molecular genetics
Published: October 29, 2021
Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting.
Journal: Journal of neuroendocrinology
Published: June 06, 2021
Author Correction: Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association.
Journal: Scientific reports
Published: May 27, 2021
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.
Journal: Neurobiology of disease
Published: August 27, 2019
Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
Journal: International journal of molecular sciences
Published: July 25, 2019
Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder.
Journal: Neuropharmacology
Published: June 20, 2019
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice.
Journal: Journal of psychopharmacology (Oxford, England)
Published: May 16, 2019
MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders.
Journal: EMBO molecular medicine
Published: January 03, 2019
Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder.
Journal: Neuropharmacology
Published: July 13, 2018
A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome.
Journal: Molecular neurobiology
Published: May 15, 2018
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
Journal: Human molecular genetics
Published: February 21, 2018
Last Updated: 09/26/2026